1
Brouwers, Rutger W.M., van der Poort, Esmée K.J., Kemps, Hareld M.C., van den Akker-van Marle, M. Elske, Kraal, Jos J.
Veröffentlicht in: Brouwers , R W M , van der Poort , E K J , Kemps , H M C , van den Akker-van Marle , M E & Kraal , J J 2021 , ' Cost-effectiveness of Cardiac Telerehabilitation With Relapse Prevention for the Treatment of Patients With Coronary Artery Disease in the Netherlands ' , JAMA Network Open , vol. 4 , no. 12 , e2136652 . https://doi.org/10.1001/jamanetworkopen.2021.36652;
2021
Veröffentlicht in: Brouwers , R W M , van der Poort , E K J , Kemps , H M C , van den Akker-van Marle , M E & Kraal , J J 2021 , ' Cost-effectiveness of Cardiac Telerehabilitation With Relapse Prevention for the Treatment of Patients With Coronary Artery Disease in the Netherlands ' , JAMA Network Open , vol. 4 , no. 12 , e2136652 . https://doi.org/10.1001/jamanetworkopen.2021.36652;
2021
2
3
de Vries, Folgerdiena M., Denig, Petra, Visser, Sipke T., Hak, Eelko, Postma, Maarten J.
Veröffentlicht in: de Vries , F M , Denig , P , Visser , S T , Hak , E & Postma , M J 2014 , ' Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands ' , Value in Health , vol. 17 , no. 2 , pp. 223-230 . https://doi.org/10.1016/j.jval.2013.12.010;
2014
Veröffentlicht in: de Vries , F M , Denig , P , Visser , S T , Hak , E & Postma , M J 2014 , ' Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands ' , Value in Health , vol. 17 , no. 2 , pp. 223-230 . https://doi.org/10.1016/j.jval.2013.12.010;
2014
4